- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02663635
Simulated Clinical Use Testing on Safe'N'Sound 1ML Stalked Passive Delivery System With Add-On Extended Finger Flanges
January 26, 2016 updated by: Nemera La Verpilliere
Simulated Clinical Use Testing on Safe'n'Sound 1mL Staked Passive Delivery System With add-on Extended Finger Flanges
A simulated clinical use testing the Save'N'Sound 1mL staked Passive Delivery System with add-on extended finger flanges
Study Overview
Detailed Description
This study aims to evaluate the safety of the use of the Safe'N'Sound 1mL staked passive delivery system cone version with add-on EFF in the prevention of needle stick injuries and to evaluate the user's satisfaction with regards to the handling characteristics of the product namely safety, design and the ease of use.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55422
- NAMSA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
The Evaluator must be:
- Minimum of age 18
- Able to understand and provide signed consent for the study
- Willing to comply with the study protocol, including being willing to answer questions and complete questionnaires
- Have no concerns about the ability to perform the simulated injections
- With no financial interest in the sponsor (Nemera) or the CRO (NAMSA)
Exclusion Criteria:
- If in the opinion of CRO, including the observer/monitor, the potential evaluator is not a good candidate for the study, including the reasons such as mental health.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Single Arm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The true failure rate of the Safe'n'Sound 1mL Staked Passive Delivery system with add-on extended finger flange
Time Frame: At time of testing, day 1
|
At time of testing, day 1
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Ease of Use
Time Frame: At time of testing, day 1
|
At time of testing, day 1
|
|
Evaluator assessment of device handling
Time Frame: At time of testing, day 1
|
At time of testing, day 1
|
|
Evaluator assessment of instructions
Time Frame: At time of testing, day 1
|
At time of testing, day 1
|
|
Evaluator assessment of improvement of device over predecessor device
Time Frame: At time of testing, day 1
|
At time of testing, day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Timothy Pratt, NAMSA
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
January 1, 2016
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
January 7, 2016
First Submitted That Met QC Criteria
January 21, 2016
First Posted (Estimate)
January 26, 2016
Study Record Updates
Last Update Posted (Estimate)
January 28, 2016
Last Update Submitted That Met QC Criteria
January 26, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1550599
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Needle Stick
-
Samsung Medical CenterCompletedNeedle Stick InjuriesKorea, Republic of
-
Superior UniversityActive, not recruitingNeedle Stick InjuriesPakistan
-
HTL-Strefa S.A.Completed
-
HTL-Strefa S.A.Completed
-
HTL-Strefa S.A.Completed
-
University of GuelphSocial Sciences and Humanities Research Council of CanadaCompletedPain | Needle StickCanada
-
Boston Children's HospitalLinde AGWithdrawn
-
Istanbul University - Cerrahpasa (IUC)Bandırma Onyedi Eylül UniversityCompletedPain | Maternal; Procedure | Newborn | Needle StickTurkey
-
Lazarski UniversityPoznan University of Medical Sciences; Medical University of BialystokCompletedCardiac Arrest | Injuries | Needle Stick | GlowePoland
-
Washington University School of MedicineCompletedBiopsy, Fine-Needle | Endosonography | Biopsy, Fine-Needle/MethodsUnited States